Ikgdar 500 mg Injection
  1. Home
  2. Pharma Products
  3. Cipla Ltd
  4. Ikgdar 500 mg Injection

Ikgdar 500 mg Injection

Ikgdar 500 mg Injection contains rituximab 500 mg, a monoclonal antibody used for certain blood cancers and autoimmune conditions. It is administered by intravenous infusion under the supervision of a qualified healthcare professional. Rituximab targets CD20-positive B cells, helping reduce abnormal B-cell activity.

BUY NOW

Category

Ikgdar 500 mg Injection is used in conditions such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, and may also be prescribed for certain autoimmune disorders. Rituximab binds to the CD20 antigen on B cells and promotes their destruction through immune-mediated mechanisms. The dose and infusion schedule are determined by the treating specialist based on the condition and treatment protocol. Medical supervision during administration is important because infusion-related reactions can occur.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Dosage Form Injection / Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 1 Vial, 50 mL
Manufacturer Emcure Pharmaceuticals Ltd.

Product Also Known As

Ikgdar 500 mg Injection, Ikgdar 500 Injection, Ikgdar Rituximab Injection, Rituximab 500 mg Injection, Rituximab 500 mg Infusion, Rituximab Monoclonal Antibody Injection